Jump to section
To create a care experience that patients love.
Gastrointestinal conditions, though relatively common, are often stigmatised, and its patient population is woefully underserved. Oshi Health is a virtual-first medical practice revolutionizing the diagnosis, management and treatment of digestive health conditions, to improve the standard of care for GI patients.
Oshi’s whole-person model and emphasis on proactive interventions has offered a transformative alternative to the reactive approach of traditional medicine. Its expert care team works to help patients gain control over their symptoms by treating them using a unique mix of dietary, psychosocial, and medication interventions. By serving the tens of millions of Americans affected by GI conditions, Oshi is filling a necessary gap in the market.
With 91% of Oshi Health members seeing symptom improvement within 10 weeks - a noticeable improvement from 2021's 85% in 3 months - it is evident that the company is dedicated to refining its offering. The significant funding it has raised will be used to accelerate the next phase of growth, including scaling its clinical team and creating new partnerships with health groups and providers.
Steph
Company Specialist at Welcome to the Jungle
Oct 2024
$60m
SERIES C
Apr 2023
$30m
SERIES B
This company has top investors
Sam Holliday
(CEO)Started as a Manager for Accenture before becoming a Healthcare Investment Banker for J.P. Morgan. Served as VP of Population Health for Greenway Medical Technologies and VP of Operations for Everyday Health, before acting as COO for Cecelia Health.